Clinical trials - Press Releases

Date	Title	Company
14-Oct-2022	New Medidata Technology Helps Sponsors and CROs Improve Diversity and Inclusion in Clinical Trials	Medidata
12-Oct-2022	RBQM market leader, CluePoints, marks its tenth anniversary as ICH E6 (R3) looks set to mandate the company’s data-driven approach across all clinical trials	CluePoints
12-Oct-2022	Tiziana Life Sciences Plans to Submit IND for Phase 1 Trial of Intranasal Foralumab in Alzheimer's Disease Patients	Tiziana Life Sciences
12-Oct-2022	InfanDx AG Reports Successful Validation of Biomarker Panels for the Early Detection of Hypoxic Ischemic Encephalopathy	InfanDx AG
11-Oct-2022	Albireo Reports Positive Topline Data from Phase 3 Trial of Bylvay® (odevixibat) in Alagille Syndrome	Albireo Pharma
11-Oct-2022	Pistoia Alliance Launches Global Community of Interest to Assess the Environmental Impact of Clinical Trials	Pistoia Alliance
11-Oct-2022	Renowned experts join Ultrahuman as it kicks off clinical trials on glucose	Ultrahuman
11-Oct-2022	TILT Biotherapeutics Announces First US Patient Dosed in Immunotherapy Clinical Trial in Ovarian Cancer	TILT Biotherapeutics
11-Oct-2022	Dupixent® (dupilumab) late-breaking Phase 3 data presented at UEG Week 2022 showed significant histological remission of eosinophilic esophagitis (EoE) in children 1 to 11 years old	Sanofi
11-Oct-2022	Clariness Selects Lacework to Future Proof Cloud Security	Lacework
10-Oct-2022	HUTCHMED Initiates a Phase II/III Trial of Sovleplenib for Warm Antibody Autoimmune Hemolytic Anemia in China	HUTCHMED
07-Oct-2022	Paradigm Clinical Research Names Industry Veteran Kurt Mussina as CEO as Expansion Plans Are Set in Motion	Paradigm Clinical Research
05-Oct-2022	atai Life Sciences Announces First Subject Dosed in Phase 1 Trial of Buccal and IV VLS-01, a Synthetic Form of DMT	atai Life Sciences N.V.
04-Oct-2022	Freeline Initiates Dosing of Second Cohort in MARVEL-1 Trial of FLT190 Gene Therapy Candidate for People with Fabry Disease	Freeline Therapeutics
29-Sep-2022	Dr. Vince Clinical Research Opens Industry-Leading Clinical Pharmacology Unit	Dr. Vince Clinical Research
28-Sep-2022	Avance Clinical Wins International Health Award for Biotech CRO Services	Avance Clinical
27-Sep-2022	Quanticate partners with Cancer Research UK to launch DETERMINE Study	Quanticate
26-Sep-2022	TolerogenixX Publishes Three-Year Follow-Up Data from Phase I Trial of Immune Tolerance-Inducing MIC-Lx Cell Therapy	TolerogeniXx GmbH
26-Sep-2022	TILT Biotherapeutics Collaborates with MSD on Immunotherapy Clinical Trial in Checkpoint Inhibitor Refractory Non-Small Cell Lung Cancer	TILT Biotherapeutics
22-Sep-2022	Data presented today show more participants achieved greater treatment satisfaction when switching to once-weekly insulin icodec in ONWARDS 2 trial	Novo Nordisk